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Reay Tannahill (1973), in her fascinating booh Food in 
History, points out that the safety and quality of foods 
has been a concern of humankind since primitive 
times. Concerns over food safety and quality magni­
fied substantially along with the development of the 
food trade, due to the widespread practice of food adul­
teration employed by earlier food purveyors. It is inter­
esting to note historically that the legislation these 
practices prompted form the basis for the development 
of modern food control legislation. But concerns over 
food safety today extend beyond the question of adul­
teration which, as we all know, is infrequently prac­
ticed by today’s food merchants. In terms of their sci­
entific importance, microbiological safety of foods is 
the predominant concern, followed by nutritional fac­
tors, natural toxicants, industrial pollutants, and fi­
nally, pesticides and food additives. The emerging sci­
ence of biotechnology and the impact it will have on 
food safety and quality is added to these traditional ar­
eas of food safety concern.
To grasp the potential food safety and regulatory is­
sues that might occur pursuant to the introduction of 
biotechnology into the food and agriculture industry, it 
is necessary to understand the nature of the issues be­
ing dealt with. An industry survey conducted in 1988 
by the Food and Drug Administration (FDA, 1988) in­
dicated that about 40 percent of the research and de­
velopment in food biotechnology was focused on im­
proved agricultural products, 43 percent was targeted 
at the food processing industry and the balance, ap­
proximately 20 percent, was targeted in the area of 
food safety diagnostics and related applications. The
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research and development programs in agriculture 
were evenly divided between livestock biotechnology, 
the bioengineering of pest resistance into food crops 
and the development of improved cultivars. In the 
food processing industry, two-thirds of the activity 
was focused on new or improved food ingredients
and food processing 
industry.
The important point 
here Is not the quan-
titative distribution of 
resources, but the 
fact that biotechnol-
ogy holds great pro-
mise for application 
in essentially all sec-
tors of the agricultural while the balance was targeted on food processing
techniques such as enzyme technology and improved 
final products. The important point here is not the 
quantitative distribution of resources, but the fact that biotechnology 
holds great promise for application in essentially all sectors of the agricul­
tural and food processing industry.
Given this breadth of application, what will the major scientific issues 
associated with the application of biotechnology to the food system be? 
Certainly the principal concern is one of food safety. A second concern re­
lates to the possible impact biotechnology will have on the nutrient com­
position of the food supply. From a government perspective, the regulatory 
issues that will undoubtedly be associated with biotechnology cannot be 
overlooked. These range from if and how biotechnology food products 
should be regulated, i.e., “Will specific product approvals be required?”, to 
the whole question of regulatory compliance procedures, including anal­
ytical requirements, labeling etc. The impact biotechnology will have on 
food safety has been evaluated by the International Food Biotechnology 
Council (IFBC, 1990) and some of these remarks are
A key premise of the 
law, however, is that 
safety standards and 
regulatory proce-
dures should be tai-
lored to the nature of 
the food substance in 
question and the po-
tential safety ques-
tions it may pose.
based on the recently completed IFBC report.
It is important to consider the legal framework in 
which we have to operate in any consideration of the 
effect of biotechnology on food safety. The overriding 
objective of current food safety laws is, of course, to 
assure that consumers are not harmed by the foods 
they eat. To achieve this objective, the law provides 
an array of safety standards and enforcement tools 
which the FDA can use to control foods that are po­
tentially harmful to health. A key premise of the law is that safety stan­
dards and regulatory procedures should be tailored to the nature of the 
food substance in question and the potential safety questions it may pose.
Whole foods are not required to undergo any pre-market review or ap­
proval by FDA. Under the law, however, any person who introduces food 
into commerce is responsible for assuring that it complies with all require-
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ments of the Food, Drug and Cosmetic Act, including the requirement that 
it meet the applicable safety standards. The FDA has enforcement powers 
under the statute that permit it to seize adulterated food, seek a court or­
der preventing its further distribution, and criminally prosecute firms and 
individuals responsible for its distribution.
The law also recognizes that the food supply contains many naturally- 
occurring substances that, when consumed alone in large amounts, are 
toxic, but that are not harmful when consumed as inherent constituents of 
food. The FDA is empowered to act against such substances if it finds that 
they render the food “ordinarily injurious” to health.
Substances added intentionally to accomplish a function in food are 
subject to yet another safety standard, and may be required to undergo 
pre-market review and approval by FDA. Even here, however, the intent is 
to foster innovation in food technology, as well as assure safety. These 
goals are achieved by adopting a protective but realistic safety standard 
and by not requiring pre-market approval when safety assurance is not re­
quired, for example, when the food substance is “generally recognized as 
safe” (GRAS). As FDA has interpreted and applied the law over the years, 
formal pre-market approval has generally been reserved for new chemicals 
and new uses of chemicals that are not GRAS. The FDA has also developed 
special procedures and practices for the regulation of GRAS substances.
Clearly, the extent of regulatory concern, as well as safety and nutri­
tional components, will vary depending upon the food product or ingredi­
ent of biotechnology being considered. To deal with the easy problems 
first, a regulatory structure already exists to ensure the safety of ingredi­
ents such as food additives and GRAS substances. It is fairly clear that new 
ingredients and even old ingredients produced through biotechnology will 
be required to meet present regulatory requirements. This covers the bulk 
of enzymes, microorganisms, food additives such as thickening agents and 
preservatives as well as GRAS food ingredients such as specific sources of 
dietary fiber, modified carbohydrates, etc. Collectively, this represents a 
vast array of substances used by the food processing industry. Except for 
specific examples, there is really nothing new about these groups of sub­
stances. Humans have used microorganisms to “process” foods for centu­
ries, albeit it is only recently that controlled fermentations have been com­
monplace. Likewise, food additives and other ingredients have enjoyed 
widespread legitimate use and are now well integrated into the technology 
of the food processor. The existing regulatory practices will apply to all 
such products. That does not mean that each new product will require for­
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To comment on the 
safety Issues asso-
ciated with biotech-
nology in the food 
processing industry,
It can be safely stated 
that existing proce-
dures for safety eval-
uation and regulatory 
control will effectively 
eliminate any poten-
tial risks that may be 
perceived to exist.
mal review by FDA. In many cases, new products 
will be considered GRAS substances. In a great many 
other cases, biotechnology is simply a convenient, 
cost-efficient way to produce existing, already ap­
proved food ingredients. To comment on the safety is­
sues associated with biotechnology in the food pro­
cessing industry, it can be safely stated that existing 
procedures for safety evaluation and regulatory con­
trol will effectively eliminate any potential risks that 
may be perceived to exist.
The primary issue in food biotechnology relates to its 
application in agriculture. The real or perceived issues associated with bo­
vine somatotropin are now familiar, along with other emerging problems 
associated with the genetic manipulation of food-producing animals. Less 
well recognized, and probably less well understood, are the issues that re­
late to the application of biotechnology in the plant kingdom. Again, the 
regulatory and food safety issues differ depending on the application and 
the end product in question. Two general categories of application can be 
envisioned. One of these relates to the use of biotechnology to produce 
herbicide, insect, drought and other forms of plant resistance by engineer­
ing foreign genetic material into the plant, while a second category relates 
more to altering the traditional characteristics of existing cultivars by the 
insertion of genetic material derived from traditional food sources. These 
latter changes might include alterations in composition; for example, im­
proved nutritional quality or improved processing characteristics, and in­
creased yield and marketability. In future years the development of new 
varieties of cultivars, at least new to our palate, might be anticipated.
A record of regulatory experience existing in plants does not yet exist in 
the safety evaluation of plants or genetic variants of existing plants. Yet a 
great deal of human experience is available—in fact, many generations of 
experience in the area of traditional plant breeding techniques. The key to 
dealing with the problem of biotechnology as applied to plants lies in large 
part, in the historical experience and the safety record of human use on 
past practices which exists but is not well documented. The experience of 
that record provides an important foundation for the safety evaluation of 
genetically-modified plants.
Primitive humans soon learned which plants were poisonous and 
should not be eaten and which were not. Yet even today, several poisonous 
plants are consumed of necessity and are stored, processed or prepared in
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such a way as to alter or eliminate their toxicity. A typical example is the 
root plant cassava which, once properly processed, provides a wholly suit­
able and nutritious basic food staple for large segments of the world’s pop­
ulation. Many other such examples exist, including soybeans, lima beans 
and even potatoes. Prudent and judicious selection of foods derived from a 
broad selection of plant fauna available to early humans provided the ge­
netic stock for the plant foods eaten today.
The introduction of plant breeding brought with it not only changes in 
genetic elements, but vast improvements in the food supply. The genetic 
lineage of modern cultivars is lost in antiquity, but a perspective on the ge­
netic variations people have historically been exposed to provides an ex­
ample of the genetic diversity inherent in the present food supply. One of 
the world’s staple foods—maize—probably originated from the wild grass 
teosinte commonly found in remote areas of Mexico and Central America. 
Selection and cultivation changed teosinte into Indian corn and finally 
into modern maize. Unquestionably, humans have been exposed to a wide 
array of genetic variants of today’s maize without apparent adverse health 
effects over time. The extent of change with time of the genetic diversity 
in the food supply becomes evident when the differences between culti­
vated plants and their wild relatives is considered. Cultivated plants usu­
ally have one or more of the following traits that are uncommon in their 
wild relatives: lessened ability to disseminate seed, 
reduced concentrations of bitter or toxic principles, 
loss of delayed germination attribute, reduced life 
span, higher harvest index or altered color and fruit 
size. This illustrates the point that we and our ancestors 
have been exposed to wide diversity of genetic material. 
This becomes important in assessing the impact of 
biotechnology on food safety.
The extent of compositional variation inherent in the foods tradition­
ally eaten is another factor to consider in assessing the safety of geneti­
cally-modified foods. Some of this variation is due to genetic differences, 
while some is due to environmental influences. Among the macronutrients 
present in commercial vegetables, intraspecies variations in protein, fat 
and carbohydrate content range from 1.5-2.5 fold. Similar variations are 
present in common commercial fruit varieties. Among essential trace ele­
ments within species, variations in composition of up to 10 fold are not un­
common. The intraspecies content of some trace elements such as sele­
The extent of compo-
sitional variation in-
herent in the foods 
traditionally eaten is 
another factor to con-
sider in assessing the 
safety of genetically- 
modified foods.
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nium may vary up to 18 fold while vitamin content varies up to approxi­
mately 4 fold. While not immediately apparent, these are very wide varia­
tions in composition. An example illustrates: if a variety of carrots that 
contains the higher of the range of vitamin A traditionally present is con­
sumed, all daily vitamin A needs from that source would essentially be met. 
But if a variety low in vitamin A is consumed, only 25 percent of the daily 
requirement would be met. This highlights the importance of understand­
ing the impact of biotechnology on the nutrient composition of foods.
A third, and probably the most important factor to consider in determin­
ing the consequences of genetic manipulation of plants, is the affect it has 
on the concentration of naturally-occurring toxic factors. This is a principal 
concern of regulatory agencies, even while recognizing that traditional 
plant breeding practices have been used to advantage to reduce levels of tox­
ic constituents. In the early 1970s, FDA cited six incidents which raised 
questions of safety regarding traditional plant breeding and which brought 
these practices under the purview of GRAS regulations. These included:
—a 60 percent increase in solanine content of potatoes grown from seed tu­
bers treated with 1,000 rads of gamma radiation to break dormancy;
—the development of a high solids potato cultivar with high solanine con­
tent;
—the hypothesis that potatoes resistant to late blight developed additional 
chemicals that are teratogenic;
—the production of the toxic chemical ipomeamarone by sweet potatoes 
under certain environmental conditions;
—the development of cultivars of food plants resistant to insect attack;
—unexpected changes in plant composition due to other varietal changes 
(the example given was reduced vitamin C in tomatoes due to mechani­
cal harvesting).
The FDA indicated that an increase in toxicants of 10 percent or more 
when compared to the parent containing the least toxicant, or a decrease in 
a principal nutrient of 20 percent or more, would require that appropriate 
analytical data be supplied to FDA in a GRAS affirmation petition.
Despite plant breeder’s concern over FDA regulation the vast majority 
of new plant varieties have not been formally reviewed under GRAS regula­
tions and have not required pre-market approval from the FDA. Nonethe­
less, we must be vigilant to the possibility that biotechnology may intro­
duce new toxic factors into plants or alter the levels of existing toxicants.
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There are now over 200 naturally-occurring toxic factors in food that 
have some potential for causing toxic effects in humans, although only 21 
have been firmly documented as causing human harm. These include both 
toxic factors in food plants and in animal feeds and forage where the toxi­
cant is passed on to human food such as milk. These are important for the 
plant breeder to consider because:
—Selection and traditional breeding practices have been among the most 
successful methods used to reduce concentrations of natural toxicants 
to levels that present no significant hazard;
—Natural toxicants will clearly be the principal point of concern in evalu­
ating the safety of foods produced by genetic modification of sources in 
which these toxicants can occur;
—It should certainly be the intent of any genetic modification to reduce, 
or at least maintain the level of any constituent that even approaches 
being a significant hazard;
—Natural toxicants are an important, and, within professional circles, a 
well-recognized source of risk in food.
As with nutrients, genetic variations may markedly alter the toxicant 
content of foods. For example, the solanine content of white table potatoes 
may vary from 2 to a high of 20 mg/100 g, a ten-fold variation. The higher 
level could represent 20 percent of the toxic dose of solanine to humans. In 
fact, during the 1970s, the U.S. Department of Agriculture (USDA) devel­
oped a potato variety (Lenape) with unusually high solids content and, 
therefore, desirable processing characteristics. This variety also derived late 
blight resistance from a wild ancestor, Solarium demissum. In the course of 
routine monitoring of incoming potatoes for glycoalkaloid (solanine) con­
tent, a food company found solanine levels several times higher than nor­
mal in the Lenape variety. The company called the problem to the atten­
tion of USDA and FDA and the variety was quickly withdrawn. Similarly, 
low cyanogen varieties of cassava yield 20 - 40 mg/kg of hydrogen cyanide 
while other varieties may yield 20 times that amount—enough to poison 
a person who is not aware of the proper processing procedures.
The examples quoted are clearly well known, but the potential for ge­
netic modification to alter the levels of less well known toxicants must 
never be overlooked. As recently as 1981, Rymal et al (1984) reported that 
as the result of quality control testing, a large commercial pack of tomato 
sauce containing squash was kept out of commerce because the squash was 
found to be extremely bitter. Samples of the fruit of this cultivar were 
found to contain unusually high levels of the extremely toxic substance
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Cucurbitacin E. This episode, as well as others where people were actually 
poisoned from home garden crops in Alabama and Australia, apparently 
resulted from a “wide cross” contamination of the cultivated seed from a 
wild relative.
Criteria for Assessing Safety and Acceptability
This provides the background to attempt to elaborate on the criteria that 
are important in assessing the safety and acceptability of genetically-mod­
ified food crops. If the process of genetic modification is intended to intro­
duce new genetic elements that result in a wholly new expression product, 
for example, a resistance factor such as a pesticide derived through enzy­
matic means, then clearly we should in theory, identify and characterize 
the substance, its range of levels of occurrence and conduct a safety evalua­
tion on it as a discrete entity if possible. If it is not possible to isolate the 
substance, it may be necessary to evaluate the safety of the whole food.
If the genetic change is intended to enhance the nutritional quality of a 
food, then documentation supporting the achieved objective would be re­
quired. If the genetic change was intended to enhance processing charac­
teristics, yield or marketability, this would likewise need to be demonstra­
ted. In all cases, a critical feature of the safety evaluation would consist of 
characterizing the nature of the introduced genetic material, particularly 
if it is not from a traditional food source. The following should be known 
about the inserted genetic material:
—the physical and functional limits of the coding region, and size and 
structure;
—the physical extent of the signal DNA regions;
—the functional properties of signals such as promoters where the se­
quence, relative strength and start of transcription are known from 
published literature or direct determinations.
—after the genetic material is introduced and an individual genetically- 
modified plant has been selected, the following additional information 
may be obtained: quantitative data on the levels and consistency of the 
expression products from the introduced gene.
—copy number of the introduced gene and vector sequences.
—documentation concerning the concentration of significant nutrients in 
the product. Significant nutrients are defined as those that contribute 
in a major way to achieving recommended daily intakes. Other nutri­
ents, though important, would not be critical to gaining acceptance of 
the product.
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Documenting the levels of any known naturally-occurring toxic fac­
tors inherent in the plant species or its close relatives. This would in­
volve analytical determinations of the precise levels of those naturally-oc­
curring toxic factors in the food on which attention should focus.
If deemed necessary, documenting that genetic manipulation has not al­
tered the physical and elemental composition of the food in such a way as 
to impinge on the microbiological safety of the food when processed in ac­
cordance with usual practices.
In practice, it is important to revise these criteria in light of the princi­
ple that the standard of safety for biotechnologically-produced foods 
should be no more or no less stringent than that required for food produced 
through conventional breeding techniques. What can be concluded about 
the impact of biotechnology on food safety? It can be stated safely that 
food ingredients and additives produced through biotechnology will not 
be a new issue to the science of food safety because of the well established 
safety evaluation practices that exist for these classes of substances.
With respect to whole foods such as genetically-modified plants, the 
extent of safety evaluation will need to be geared to the nature of the in­
duced genetic change. Given the specificity of modern techniques in mo­
lecular biology, as applied to biotechnology, changes in genetic composi­
tion hopefully could be characterized with greater ease and more precision 
than in the past. The genetic alterations induced through genetic engineer­
ing probably would not be as extensive as those induced through tradi­
tional breeding practices, especially wide crosses.This 
tends to limit the extent of compositional change 
that might occur. The degree of government regula­
tory oversight required will depend on the degree of 
technical excellence the industry demonstrates. The 
reward for adequately characterizing introduced ge­
netic material, and providing other data referred to 
will be reduced time to approval in cases where pre­
market approval is required. The penalty for failing to 
do so will be increased regulatory scrutiny consisting 
of repeated requests for more data, more complete explanations, and, 
worst of all, requests to test the new product in extensive animal feeding 
trials. This is to be avoided in the name of good science.
The science of food safety has the tools and the know-how to provide a 
rigorous safety evaluation of new products. If good science leads, fair regu­
lation will surely follow.
The science of food 
safety has the tools 
and the know-how 
to provide a rigorous 
safety evaluation of 
new products. If good 
science leads, fair 
regulation will 
surely follow.
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